Works by Kwak, Jae


Results: 370
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Fatty Acid Derivatives Isolated from the Oil of Persea americana (Avocado) Protects against Neomycin-Induced Hair Cell Damage.

    Published in:
    Plants (2223-7747), 2021, v. 10, n. 1, p. 171, doi. 10.3390/plants10010171
    By:
    • Park, SeonJu;
    • Jeong, Seo Yule;
    • Nam, Youn Hee;
    • Park, Jun Hyung;
    • Rodriguez, Isabel;
    • Shim, Ji Heon;
    • Yasmin, Tamanna;
    • Kwak, Hee Jae;
    • Oh, Youngse;
    • Oh, Mira;
    • Lee, Kye Wan;
    • Lee, Jung Suk;
    • Kim, Do Hoon;
    • Park, Yu Hwa;
    • Moon, In Seok;
    • Choung, Se-Young;
    • Jeong, Kwang Won;
    • Hong, Bin Na;
    • Kim, Seung Hyun;
    • Kang, Tong Ho
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study.

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1355, doi. 10.4143/crt.2023.271
    By:
    • Yu Ri Kim;
    • Jin Seok Kim;
    • Won Seog Kim;
    • Hyeon Seok Eom;
    • Deok-Hwan Yang;
    • Sung Hwa Bae;
    • Hyo Jung Kim;
    • Jae Hoon Lee;
    • Suk-Joong Oh;
    • Sung-Soo Yoon;
    • Jae-Yong Kwak;
    • Chul Won Choi;
    • Min Kyoung Kim;
    • Sung Young Oh;
    • Hye Jin Kang;
    • Seung Hyun Nam;
    • Hyeok Shim;
    • Joon Seong Park;
    • Yeung-Chul Mun;
    • Cheolwon Suh
    Publication type:
    Article
    26

    Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 2, p. 684, doi. 10.4143/crt.2022.1434
    By:
    • Hyungwoo Cho;
    • Dok Hyun Yoon;
    • Dong-Yeop Shin;
    • Youngil Koh;
    • Sung-Soo Yoon;
    • Seok Jin Kim;
    • Young Rok Do;
    • Gyeong-Won Lee;
    • Jae-Yong Kwak;
    • Yong Park;
    • Min Kyoung Kim;
    • Hye Jin Kang;
    • Jun Ho Yi;
    • Kwai Han Yoo;
    • Won Sik Lee;
    • Byeong Bae Park;
    • Jae Cheol Jo;
    • Hyeon-Seok Eom;
    • Hyo Jung Kim;
    • Seong Hyun Jeong
    Publication type:
    Article
    27
    28

    Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin’s Lymphoma: A Multicenter Randomized Phase II Study by the Consortium for Improving Survival of Lymphoma (CISL).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 1, p. 304, doi. 10.4143/crt.2022.004
    By:
    • Kyoung Ha Kim;
    • Jae Hoon Lee;
    • Mark Lee;
    • Hoon-Gu Kim;
    • Young Rok Do;
    • Yong Park;
    • Sung Yong Oh;
    • Ho-Jin Shin;
    • Won Seog Kim;
    • Seong Kyu Park;
    • Jee Hyun Kong;
    • Moo-Rim Park;
    • Deok-Hwan Yang;
    • Jae-Yong Kwak;
    • Hye Jin Kang;
    • Yeung-Chul Mun;
    • Jong-Ho Won
    Publication type:
    Article
    29

    Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study.

    Published in:
    Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1268, doi. 10.4143/crt.2021.1168
    By:
    • Seong Hyun Jeong;
    • Seok Jin Kim;
    • Dok Hyun Yoon;
    • Yong Park;
    • Hye Jin Kang;
    • Youngil Koh;
    • Gyeong-Won Lee;
    • Won-Sik Lee;
    • Deok-Hwan Yang;
    • Young Rok Do;
    • Min Kyoung Kim;
    • Kwai Han Yoo;
    • Yoon Seok Choi;
    • Hwan Jung Yun;
    • Jun Ho Yi;
    • Jae-Cheol Jo;
    • Hyeon-Seok Eom;
    • Jae-Yong Kwak;
    • Ho-Jin Shin;
    • Byeong Bae Park
    Publication type:
    Article
    30

    Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-47198-4
    By:
    • Changhee Park;
    • Ho Sup Lee;
    • Ka-Won Kang;
    • Won-Sik Lee;
    • Young Rok Do;
    • Jae-Yong Kwak;
    • Ho-Jin Shin;
    • Sung-Yong Kim;
    • Jun Ho Yi;
    • Sung-Nam Lim;
    • Jeong-Ok Lee;
    • Deok-Hwan Yang;
    • Hun Jang;
    • Byoungsan Choi;
    • Jiwoo Lim;
    • Choong Hyun Sun;
    • Ja Min Byun;
    • Sung-Soo Yoon;
    • Youngil Koh
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 11, p. 2714, doi. 10.1080/10428194.2020.1783448
    By:
    • Song, Ga-Young;
    • Jung, Sung-Hoon;
    • Lee, Je-Jung;
    • Kim, Jin Seok;
    • Min, Chang-Ki;
    • Kim, Kihyun;
    • Choi, Yunsuk;
    • Eom, Hyeon-Seok;
    • Joo, Young Don;
    • Kim, Sung-Hyun;
    • Kwak, Jae-Yong;
    • Kang, Hye Jin;
    • Lee, Jae Hoon;
    • Lee, Ho Sup;
    • Mun, Yeung-Chul;
    • Moon, Joon Ho;
    • Sohn, Sang Kyun;
    • Park, Seong Kyu;
    • Park, Yong;
    • Shin, Ho-Jin
    Publication type:
    Article